http://www.sciencemag.org/news/2020/11/after-dosing-mix-latest-covid-19-vaccine-success-comes-big-question-mark

Vials of the University of Oxford’s and AstraZeneca’s vaccine candidate in a facility in Anagni, Italy, which will participate in large-scale production of the vaccine after regulatory approval.

Science’s COVID-19 reporting is supported by the Pulitzer Center and the Heising-Simons Foundation.